Fermenta Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 928.63 million compared to INR 899.85 million a year ago. Revenue was INR 940.28 million compared to INR 906.75 million a year ago. Net loss was INR 80.43 million compared to net income of INR 97.98 million a year ago. Basic loss per share from continuing operations was INR 2.79 compared to basic earnings per share from continuing operations of INR 3.4 a year ago. Diluted loss per share from continuing operations was INR 2.79 compared to diluted earnings per share from continuing operations of INR 3.39 a year ago.
For the nine months, sales was INR 3,023.57 million compared to INR 2,778.04 million a year ago. Revenue was INR 3,076.13 million compared to INR 2,814.2 million a year ago. Net income was INR 77.68 million compared to INR 381.11 million a year ago. Basic earnings per share from continuing operations was INR 2.69 compared to INR 13.21 a year ago. Diluted earnings per share from continuing operations was INR 2.68 compared to INR 13.16 a year ago.